{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Autoimmune diseases", "Celastrol", "Immune modulation", "Inflammation", "Metabolic disorders", "Natural products", "Neurodegenerative diseases", "Traditional Chinese medicine"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27671821", "DateCompleted": {"Year": "2017", "Month": "06", "Day": "01"}, "DateRevised": {"Year": "2021", "Month": "12", "Day": "04"}, "Article": {"ArticleDate": [], "ELocationID": [], "Language": ["eng"], "Journal": {"ISSN": "0065-2598", "JournalIssue": {"Volume": "928", "PubDate": {"Year": "2016"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv Exp Med Biol"}, "ArticleTitle": "Celastrol and Its Role in Controlling\u00a0Chronic Diseases.", "Pagination": {"StartPage": "267", "EndPage": "289", "MedlinePgn": "267-289"}, "Abstract": {"AbstractText": ["Celastrol, a triterpenoid derived from traditional Chinese medicinal plants, has anti-inflammatory, antioxidant, and anticancer activities. Celastrol has shown preventive/therapeutic effects in experimental models of several chronic diseases. These include, chronic inflammatory and autoimmune diseases (e.g., rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, and psoriasis), neurodegenerative disorders (e.g., Alzheimer's disease, Parkinson's disease, and Amyotrophic lateral sclerosis), atherosclerosis, obesity, Type 2 diabetes, and cancer. Celastrol modulates intricate cellular pathways and networks associated with disease pathology, and it interrupts or redirects the aberrant cellular and molecular events so as to limit disease progression and facilitate recovery, where feasible. The major cell signaling pathways modulated by celastrol include the NF-kB pathway, MAPK pathway, JAK/STAT pathway, PI3K/Akt/mTOR pathway, and antioxidant defense mechanisms. Furthermore, celastrol modulates cell proliferation, apoptosis, proteasome activity, heat-shock protein response, innate and adaptive immune responses, angiogenesis, and bone remodeling. Current understanding of the mechanisms of action of celastrol and information about its disease-modulating activities in experimental models have set the stage for testing celastrol in clinical studies as a therapeutic agent for several chronic human diseases."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 W. Baltimore Street, HSF-1, Suite-380, Baltimore, MD, 21201, USA."}], "LastName": "Venkatesha", "ForeName": "Shivaprasad H", "Initials": "SH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology and Immunology, University of Maryland School of Medicine, 685 W. Baltimore Street, HSF-1, Suite-380, Baltimore, MD, 21201, USA. kmoudgil@som.umaryland.edu."}, {"Identifier": [], "Affiliation": "Division of Rheumatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. kmoudgil@som.umaryland.edu."}], "LastName": "Moudgil", "ForeName": "Kamal D", "Initials": "KD"}], "GrantList": [{"GrantID": "R01 AT004321", "Acronym": "AT", "Agency": "NCCIH NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiogenesis Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Pentacyclic Triterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Triterpenes"}, {"RegistryNumber": "L8GG98663L", "NameOfSubstance": "celastrol"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Angiogenesis Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Autoimmune Diseases"}, {"QualifierName": [], "DescriptorName": "Chronic Disease"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Pentacyclic Triterpenes"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Triterpenes"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jin HZ, Hwang BY, Kim HS, Lee JH, Kim YH, Lee JJ (2002) Antiinflammatory constituents of Celastrus orbiculatus inhibit the NF-kappaB activation and NO production. J Nat Prod 65 (1):89\u201391", "ArticleIdList": ["11809076"]}, {"Citation": "Luo DQ, Wang H, Tian X, Shao HJ, Liu JK (2005) Antifungal properties of pristimerin and celastrol isolated from Celastrus hypoleucus. Pest Manag Sci 61 (1):85\u201390. doi:10.1002/ps.953", "ArticleIdList": ["10.1002/ps.953", "15593077"]}, {"Citation": "Tong L, Moudgil KD (2007) Celastrus aculeatus Merr. suppresses the induction and progression of autoimmune arthritis by modulating immune response to heat-shock protein 65. Arthritis Res Ther 9 (4):R70. doi:10.1186/ar2268", "ArticleIdList": ["10.1186/ar2268", "PMC2206370", "17645785"]}, {"Citation": "Sethi G, Ahn KS, Pandey MK, Aggarwal BB (2007) Celastrol, a novel triterpene, potentiates TNF-induced apoptosis and suppresses invasion of tumor cells by inhibiting NF-kappaB-regulated gene products and TAK1-mediated NF-kappaB activation. Blood 109 (7):2727\u20132735. doi:10.1182/blood-2006-10-050807", "ArticleIdList": ["10.1182/blood-2006-10-050807", "17110449"]}, {"Citation": "Wong KF, Yuan Y, Luk JM (2012) Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents. Clin Exp Pharmacol Physiol 39 (3):311\u2013320. doi:10.1111/j.1440-1681.2011.05586.x", "ArticleIdList": ["10.1111/j.1440-1681.2011.05586.x", "21834865"]}, {"Citation": "Salminen A, Lehtonen M, Paimela T, Kaarniranta K (2010) Celastrol: Molecular targets of Thunder God Vine. Biochem Biophys Res Commun 394 (3):439\u2013442. doi:10.1016/j.bbrc.2010.03.050", "ArticleIdList": ["10.1016/j.bbrc.2010.03.050", "20226165"]}, {"Citation": "Kannaiyan R, Shanmugam MK, Sethi G (2011) Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett 303 (1):9\u201320. doi:10.1016/j.canlet.2010.10.025", "ArticleIdList": ["10.1016/j.canlet.2010.10.025", "21168266"]}, {"Citation": "Venkatesha SH, Yu H, Rajaiah R, Tong L, Moudgil KD (2011) Celastrus-derived celastrol suppresses autoimmune arthritis by modulating antigen-induced cellular and humoral effector responses. J Biol Chem 286 (17):15138\u201315146. doi:10.1074/jbc.M111.226365", "ArticleIdList": ["10.1074/jbc.M111.226365", "PMC3083183", "21402700"]}, {"Citation": "Nanjundaiah SM, Venkatesha SH, Yu H, Tong L, Stains JP, Moudgil KD (2012) Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk. J Biol Chem 287 (26):22216\u201322226. doi:10.1074/jbc.M112.356816", "ArticleIdList": ["10.1074/jbc.M112.356816", "PMC3381183", "22549786"]}, {"Citation": "Wang Y, Cao L, Xu LM, Cao FF, Peng B, Zhang X, Shen YF, Uzan G, Zhang DH (2015) Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems. J Neuroimmune Pharmacol. doi:10.1007/s11481-015-9598-9", "ArticleIdList": ["10.1007/s11481-015-9598-9", "25773257"]}, {"Citation": "Shaker ME, Ashamallah SA, Houssen ME (2014) Celastrol ameliorates murine colitis via modulating oxidative stress, inflammatory cytokines and intestinal homeostasis. Chem Biol Interact 210:26\u201333. doi:10.1016/j.cbi.2013.12.007", "ArticleIdList": ["10.1016/j.cbi.2013.12.007", "24384223"]}, {"Citation": "Faust K, Gehrke S, Yang Y, Yang L, Beal MF, Lu B (2009) Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson\u2019s disease. BMC Neurosci 10:109. doi:10.1186/1471-2202-10-109", "ArticleIdList": ["10.1186/1471-2202-10-109", "PMC3152779", "19723328"]}, {"Citation": "Liu Z, Ma L, Zhou GB (2011) The main anticancer bullets of the Chinese medicinal herb, thunder god vine. Molecules 16 (6):5283\u20135297. doi:10.3390/molecules16065283", "ArticleIdList": ["10.3390/molecules16065283", "PMC6264543", "21701438"]}, {"Citation": "Abbas Bukhari SN, Jantan I, Seyed MA (2015) Effects of Plants and Isolates of Celastraceae Family on Cancer Pathways. Anticancer Agents Med Chem", "ArticleIdList": ["25783963"]}, {"Citation": "Yadav VR, Prasad S, Sung B, Kannappan R, Aggarwal BB (2010) Targeting inflammatory pathways by triterpenoids for prevention and treatment of cancer. Toxins (Basel) 2 (10):2428\u20132466. doi:10.3390/toxins2102428", "ArticleIdList": ["10.3390/toxins2102428", "PMC3153165", "22069560"]}, {"Citation": "Lee JH, Koo TH, Yoon H, Jung HS, Jin HZ, Lee K, Hong YS, Lee JJ (2006) Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem Pharmacol 72 (10):1311\u20131321. doi:10.1016/j.bcp.2006.08.014", "ArticleIdList": ["10.1016/j.bcp.2006.08.014", "16984800"]}, {"Citation": "Trott A, West JD, Klaic L, Westerheide SD, Silverman RB, Morimoto RI, Morano KA (2008) Activation of heat shock and antioxidant responses by the natural product celastrol: transcriptional signatures of a thiol-targeted molecule. Mol Biol Cell 19 (3):1104\u20131112. doi:10.1091/mbc.E07-10-1004", "ArticleIdList": ["10.1091/mbc.E07-10-1004", "PMC2262981", "18199679"]}, {"Citation": "Narayan V, Ravindra KC, Chiaro C, Cary D, Aggarwal BB, Henderson AJ, Prabhu KS (2011) Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication. Journal of molecular biology 410 (5):972\u2013983", "ArticleIdList": ["PMC3140654", "21763500"]}, {"Citation": "Cascao R, Vidal B, Raquel H, Neves-Costa A, Figueiredo N, Gupta V, Fonseca JE, Moita LF (2012) Effective treatment of rat adjuvant-induced arthritis by celastrol. Autoimmun Rev 11 (12):856\u2013862. doi:10.1016/j.autrev.2012.02.022", "ArticleIdList": ["10.1016/j.autrev.2012.02.022", "PMC3582326", "22415021"]}, {"Citation": "Astry B, Venkatesha SH, Laurence A, Christensen-Quick A, Garzino-Demo A, Frieman MB, O\u2019Shea JJ, Moudgil KD (2015) Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ. Clin Immunol 157 (2):228\u2013238. doi:10.1016/j.clim.2015.01.011", "ArticleIdList": ["10.1016/j.clim.2015.01.011", "PMC4410084", "25660987"]}, {"Citation": "Li G, Liu D, Zhang Y, Qian Y, Zhang H, Guo S, Sunagawa M, Hisamitsu T, Liu Y (2013) Celastrol inhibits lipopolysaccharide-stimulated rheumatoid fibroblast-like synoviocyte invasion through suppression of TLR4/NF-kappaB-mediated matrix metalloproteinase-9 expression. PLoS One 8 (7):e68905. doi:10.1371/journal.pone.0068905", "ArticleIdList": ["10.1371/journal.pone.0068905", "PMC3701694", "23861949"]}, {"Citation": "Abdin AA, Hasby EA (2014) Modulatory effect of celastrol on Th1/Th2 cytokines profile, TLR2 and CD3+ T-lymphocyte expression in a relapsing-remitting model of multiple sclerosis in rats. Eur J Pharmacol 742:102\u2013112. doi:10.1016/j.ejphar.2014.09.001", "ArticleIdList": ["10.1016/j.ejphar.2014.09.001", "25218987"]}, {"Citation": "Li H, Zhang YY, Huang XY, Sun YN, Jia YF, Li D (2005) Beneficial effect of tripterine on systemic lupus erythematosus induced by active chromatin in BALB/c mice. Eur J Pharmacol 512 (2\u20133):231\u2013237. doi:10.1016/j.ejphar.2005.02.030", "ArticleIdList": ["10.1016/j.ejphar.2005.02.030", "15840409"]}, {"Citation": "Xu C, Wu Z (2002) [The effect of tripterine in prevention of glomerulosclerosis in lupus nephritis mice]. Zhonghua Nei Ke Za Zhi 41 (5):317\u2013321", "ArticleIdList": ["12133425"]}, {"Citation": "Xu X, Zhong J, Wu Z, Fang Y, Xu C (2007) Effects of tripterine on mRNA expression of TGF-beta1 and collagen IV expression in BW F1 mice. Cell Biochem Funct 25 (5):501\u2013507. doi:10.1002/cbf.1338", "ArticleIdList": ["10.1002/cbf.1338", "16929507"]}, {"Citation": "Kim DY, Park JW, Jeoung D, Ro JY (2009) Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. Eur J Pharmacol 612 (1\u20133):98\u2013105. doi:10.1016/j.ejphar.2009.03.078", "ArticleIdList": ["10.1016/j.ejphar.2009.03.078", "19356734"]}, {"Citation": "Kim Y, Kim K, Lee H, Han S, Lee YS, Choe J, Kim YM, Hahn JH, Ro JY, Jeoung D (2009) Celastrol binds to ERK and inhibits FcepsilonRI signaling to exert an anti-allergic effect. Eur J Pharmacol 612 (1\u20133):131\u2013142. doi:10.1016/j.ejphar.2009.03.071", "ArticleIdList": ["10.1016/j.ejphar.2009.03.071", "19356729"]}, {"Citation": "Liu RL, Liu ZL, Li Q, Qiu ZM, Lu HJ, Yang ZM, Hong GC (2004) [The experimental study on the inhibitory effect of tripterine on airway inflammation in asthmatic mice]. Zhonghua Jie He He Hu Xi Za Zhi 27 (3):165\u2013168", "ArticleIdList": ["15130326"]}, {"Citation": "Zhang LX, Yu FK, Zheng QY, Fang Z, Pan DJ (1990) [Immunosuppressive and antiinflammatory activities of tripterine]. Yao Xue Xue Bao 25 (8):573\u2013577", "ArticleIdList": ["2082679"]}, {"Citation": "Allison AC, Cacabelos R, Lombardi VR, Alvarez XA, Vigo C (2001) Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer\u2019s disease. Progress in neuro-psychopharmacology & biological psychiatry 25 (7):1341\u20131357", "ArticleIdList": ["11513350"]}, {"Citation": "Choi BS, Kim H, Lee HJ, Sapkota K, Park SE, Kim S, Kim SJ (2014) Celastrol from \u2018Thunder God Vine\u2019 protects SH-SY5Y cells through the preservation of mitochondrial function and inhibition of p38 MAPK in a rotenone model of Parkinson\u2019s disease. Neurochem Res 39 (1):84\u201396. doi:10.1007/s11064-013-1193-y", "ArticleIdList": ["10.1007/s11064-013-1193-y", "24214023"]}, {"Citation": "Chow AM, Brown IR (2007) Induction of heat shock proteins in differentiated human and rodent neurons by celastrol. Cell Stress Chaperones 12 (3):237\u2013244", "ArticleIdList": ["PMC1971233", "17915556"]}, {"Citation": "Chow AM, Tang DW, Hanif A, Brown IR (2014) Localization of heat shock proteins in cerebral cortical cultures following induction by celastrol. Cell Stress Chaperones 19 (6):845\u2013851. doi:10.1007/s12192-014-0508-5", "ArticleIdList": ["10.1007/s12192-014-0508-5", "PMC4389844", "24700193"]}, {"Citation": "Cleren C, Calingasan NY, Chen J, Beal MF (2005) Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. Journal of neurochemistry 94 (4):995\u20131004. doi:10.1111/j.1471-4159.2005.03253.x", "ArticleIdList": ["10.1111/j.1471-4159.2005.03253.x", "16092942"]}, {"Citation": "Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF (2005) Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis 2 (5):246\u2013254. doi:10.1159/000090364", "ArticleIdList": ["10.1159/000090364", "16909005"]}, {"Citation": "Paris D, Ganey NJ, Laporte V, Patel NS, Beaulieu-Abdelahad D, Bachmeier C, March A, Ait-Ghezala G, Mullan MJ (2010) Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer\u2019s disease. J Neuroinflammation 7:17. doi:10.1186/1742-2094-7-17", "ArticleIdList": ["10.1186/1742-2094-7-17", "PMC2841120", "20211007"]}, {"Citation": "Tabuchi H, Konishi M, Saito N, Kato M, Mimura M (2014) Reverse Fox test for detecting visuospatial dysfunction corresponding to parietal hypoperfusion in mild Alzheimer\u2019s disease. Am J Alzheimers Dis Other Demen 29 (2):177\u2013182. doi:10.1177/1533317513511291", "ArticleIdList": ["10.1177/1533317513511291", "PMC10852913", "24226465"]}, {"Citation": "Yang C, Swallows CL, Zhang C, Lu J, Xiao H, Brady RO, Zhuang Z (2014) Celastrol increases glucocerebrosidase activity in Gaucher disease by modulating molecular chaperones. Proc Natl Acad Sci U S A 111 (1):249\u2013254. doi:10.1073/pnas.1321341111", "ArticleIdList": ["10.1073/pnas.1321341111", "PMC3890874", "24351928"]}, {"Citation": "Paimela T, Hyttinen JM, Viiri J, Ryhanen T, Karjalainen RO, Salminen A, Kaarniranta K (2011) Celastrol regulates innate immunity response via NF-kappaB and Hsp70 in human retinal pigment epithelial cells. Pharmacol Res 64 (5):501\u2013508. doi:10.1016/j.phrs.2011.05.027", "ArticleIdList": ["10.1016/j.phrs.2011.05.027", "21683142"]}, {"Citation": "Hu H, Straub A, Tian Z, Bassler N, Cheng J, Peter K (2009) Celastrol, a triterpene extracted from Tripterygium wilfordii Hook F, inhibits platelet activation. J Cardiovasc Pharmacol 54 (3):240\u2013245. doi:10.1097/FJC.0b013e3181b21472", "ArticleIdList": ["10.1097/FJC.0b013e3181b21472", "19661812"]}, {"Citation": "Gu L, Bai W, Li S, Zhang Y, Han Y, Gu Y, Meng G, Xie L, Wang J, Xiao Y, Shan L, Zhou S, Wei L, Ferro A, Ji Y (2013) Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress. PLoS One 8 (6):e65477.", "ArticleIdList": ["PMC3684610", "23799016"]}, {"Citation": "Liu J, Lee J, Salazar Hernandez MA, Mazitschek R, Ozcan U (2015) Treatment of obesity with celastrol. Cell 161 (5):999\u20131011. doi:10.1016/j.cell.2015.05.011", "ArticleIdList": ["10.1016/j.cell.2015.05.011", "PMC4768733", "26000480"]}, {"Citation": "Kim JE, Lee MH, Nam DH, Song HK, Kang YS, Lee JE, Kim HW, Cha JJ, Hyun YY, Han SY, Han KH, Han JY, Cha DR (2013) Celastrol, an NF-kappaB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice. PLoS One 8 (4):e62068.", "ArticleIdList": ["PMC3637455", "23637966"]}, {"Citation": "Youn GS, Kwon DJ, Ju SM, Rhim H, Bae YS, Choi SY, Park J (2014) Celastrol ameliorates HIV-1 Tat-induced inflammatory responses via NF-kappaB and AP-1 inhibition and heme oxygenase-1 induction in astrocytes. Toxicol Appl Pharmacol 280 (1):42\u201352. doi:10.1016/j.taap.2014.07.010", "ArticleIdList": ["10.1016/j.taap.2014.07.010", "25064159"]}, {"Citation": "Tallorin L, Durrant JD, Nguyen QG, McCammon JA, Burkart MD (2014) Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase. Bioorganic & medicinal chemistry 22 (21):6053\u20136061", "ArticleIdList": ["PMC4807855", "25284249"]}, {"Citation": "Simmonds RE, Foxwell BM (2008) Signalling, inflammation and arthritis: NF-kappaB and its relevance to arthritis and inflammation. Rheumatology (Oxford) 47 (5):584\u2013590. doi:10.1093/rheumatology/kem298", "ArticleIdList": ["10.1093/rheumatology/kem298", "18234712"]}, {"Citation": "Tak PP, Firestein GS (2001) NF-kappaB: a key role in inflammatory diseases. J Clin Invest 107 (1):7\u201311. doi:10.1172/JCI11830", "ArticleIdList": ["10.1172/JCI11830", "PMC198552", "11134171"]}, {"Citation": "Bondeson J, Foxwell B, Brennan F, Feldmann M (1999) Defining therapeutic targets by using adenovirus: blocking NF-kappaB inhibits both inflammatory and destructive mechanisms in rheumatoid synovium but spares anti-inflammatory mediators. Proc Natl Acad Sci U S A 96 (10):5668\u20135673", "ArticleIdList": ["PMC21918", "10318942"]}, {"Citation": "Ju SM, Youn GS, Cho YS, Choi SY, Park J (2015) Celastrol ameliorates cytokine toxicity and pro-inflammatory immune responses by suppressing NF-kappaB activation in RINm5F beta cells. BMB Rep 48 (3):172\u2013177", "ArticleIdList": ["PMC4453024", "25059279"]}, {"Citation": "Hommes DW, Peppelenbosch MP, van Deventer SJ (2003) Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52 (1):144\u2013151", "ArticleIdList": ["PMC1773518", "12477778"]}, {"Citation": "Kaminska B (2005) MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits. Biochim Biophys Acta 1754 (1\u20132):253\u2013262. doi:10.1016/j.bbapap.2005.08.017", "ArticleIdList": ["10.1016/j.bbapap.2005.08.017", "16198162"]}, {"Citation": "Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ (1996) FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 15 (17):4629\u20134642", "ArticleIdList": ["PMC452194", "8887554"]}, {"Citation": "Pierrat B, Correia JS, Mary JL, Tomas-Zuber M, Lesslauer W (1998) RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK). J Biol Chem 273 (45):29661\u201329671", "ArticleIdList": ["9792677"]}, {"Citation": "Jung HW, Chung YS, Kim YS, Park YK (2007) Celastrol inhibits production of nitric oxide and proinflammatory cytokines through MAPK signal transduction and NF-kappaB in LPS-stimulated BV-2 microglial cells. Exp Mol Med 39 (6):715\u2013721. doi:10.1038/emm.2007.78", "ArticleIdList": ["10.1038/emm.2007.78", "18160842"]}, {"Citation": "Kannaiyan R, Manu KA, Chen L, Li F, Rajendran P, Subramaniam A, Lam P, Kumar AP, Sethi G (2011) Celastrol inhibits tumor cell proliferation and promotes apoptosis through the activation of c-Jun N-terminal kinase and suppression of PI3 K/Akt signaling pathways. Apoptosis 16 (10):1028\u20131041", "ArticleIdList": ["21786165"]}, {"Citation": "Kim DH, Shin EK, Kim YH, Lee BW, Jun JG, Park JH, Kim JK (2009) Suppression of inflammatory responses by celastrol, a quinone methide triterpenoid isolated from Celastrus regelii. Eur J Clin Invest 39 (9):819\u2013827. doi:10.1111/j.1365-2362.2009.02186.x", "ArticleIdList": ["10.1111/j.1365-2362.2009.02186.x", "19549173"]}, {"Citation": "Zhu H, Liu XW, Cai TY, Cao J, Tu CX, Lu W, He QJ, Yang B (2010) Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway. J Pharmacol Exp Ther 334 (2):489\u2013499. doi:10.1124/jpet.110.165654", "ArticleIdList": ["10.1124/jpet.110.165654", "20472666"]}, {"Citation": "Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3 (11):900\u2013911. doi:10.1038/nri1226", "ArticleIdList": ["10.1038/nri1226", "14668806"]}, {"Citation": "Darnell JE Jr. (1997) STATs and gene regulation. Science 277 (5332):1630\u20131635", "ArticleIdList": ["9287210"]}, {"Citation": "Kannaiyan R, Hay HS, Rajendran P, Li F, Shanmugam MK, Vali S, Abbasi T, Kapoor S, Sharma A, Kumar AP, Chng WJ, Sethi G (2011) Celastrol inhibits proliferation and induces chemosensitization through down-regulation of NF-kappaB and STAT3 regulated gene products in multiple myeloma cells. Br J Pharmacol 164 (5):1506\u20131521. doi:10.1111/j.1476-5381.2011.01449.x", "ArticleIdList": ["10.1111/j.1476-5381.2011.01449.x", "PMC3221104", "21506956"]}, {"Citation": "Rajendran P, Li F, Shanmugam MK, Kannaiyan R, Goh JN, Wong KF, Wang W, Khin E, Tergaonkar V, Kumar AP, Luk JM, Sethi G (2012) Celastrol suppresses growth and induces apoptosis of human hepatocellular carcinoma through the modulation of STAT3/JAK2 signaling cascade in vitro and in vivo. Cancer Prev Res (Phila) 5 (4):631\u2013643. doi:10.1158/1940-6207.CAPR-11-0420", "ArticleIdList": ["10.1158/1940-6207.CAPR-11-0420", "22369852"]}, {"Citation": "Chen S, Gu C, Xu C, Zhang J, Xu Y, Ren Q, Guo M, Huang S, Chen L (2014) Celastrol prevents cadmium-induced neuronal cell death via targeting JNK and PTEN-Akt/mTOR network. Journal of neurochemistry 128 (2):256\u2013266. doi:10.1111/jnc.12474", "ArticleIdList": ["10.1111/jnc.12474", "PMC4183230", "24111524"]}, {"Citation": "Ma J, Han LZ, Liang H, Mi C, Shi H, Lee JJ, Jin X (2014) Celastrol inhibits the HIF-1alpha pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells. Oncol Rep 32 (1):235\u2013242. doi:10.3892/or.2014.3211", "ArticleIdList": ["10.3892/or.2014.3211", "24859482"]}, {"Citation": "Mabuchi S, Kuroda H, Takahashi R, Sasano T (2015) The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer. Gynecol Oncol 137 (1):173\u2013179. doi:10.1016/j.ygyno.2015.02.003", "ArticleIdList": ["10.1016/j.ygyno.2015.02.003", "25677064"]}, {"Citation": "Sha M, Ye J, Zhang LX, Luan ZY, Chen YB, Huang JX (2014) Celastrol induces apoptosis of gastric cancer cells by miR-21 inhibiting PI3K/Akt-NF-kappaB signaling pathway. Pharmacology 93 (1\u20132):39\u201346. doi:10.1159/000357683", "ArticleIdList": ["10.1159/000357683", "24434352"]}, {"Citation": "Shrivastava S, Jeengar MK, Reddy VS, Reddy GB, Naidu VG (2015) Anticancer effect of celastrol on human triple negative breast cancer: Possible involvement of oxidative stress, mitochondrial dysfunction, apoptosis and PI3K/Akt pathways. Exp Mol Pathol 98 (3):313\u2013327. doi:10.1016/j.yexmp.2015.03.031", "ArticleIdList": ["10.1016/j.yexmp.2015.03.031", "25818165"]}, {"Citation": "Zhao J, Sun Y, Shi P, Dong JN, Zuo LG, Wang HG, Gong JF, Li Y, Gu LL, Li N, Li JS, Zhu WM (2015) Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy. Int Immunopharmacol 26 (1):221\u2013228. doi:10.1016/j.intimp.2015.03.033", "ArticleIdList": ["10.1016/j.intimp.2015.03.033", "25858875"]}, {"Citation": "Polivka J Jr., Janku F (2014) Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther 142 (2):164\u2013175. doi:10.1016/j.pharmthera.2013.12.004", "ArticleIdList": ["10.1016/j.pharmthera.2013.12.004", "24333502"]}, {"Citation": "Hudson CC, Liu M, Chiang GG, Otterness DM, Loomis DC, Kaper F, Giaccia AJ, Abraham RT (2002) Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol 22 (20):7004\u20137014", "ArticleIdList": ["PMC139825", "12242281"]}, {"Citation": "Han X, Sun S, Zhao M, Cheng X, Chen G, Lin S, Guan Y, Yu X (2014) Celastrol stimulates hypoxia-inducible factor-1 activity in tumor cells by initiating the ROS/Akt/p70S6K signaling pathway and enhancing hypoxia-inducible factor-1alpha protein synthesis. PLoS One 9 (11):e112470. doi:10.1371/journal.pone.0112470", "ArticleIdList": ["10.1371/journal.pone.0112470", "PMC4226555", "25383959"]}, {"Citation": "Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM (2009) Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29 (10):2570\u20132581. doi:10.1128/MCB.00166-09", "ArticleIdList": ["10.1128/MCB.00166-09", "PMC2682037", "19273585"]}, {"Citation": "Onnis B, Rapisarda A, Melillo G (2009) Development of HIF-1 inhibitors for cancer therapy. J Cell Mol Med 13 (9A):2780\u20132786. doi:10.1111/j.1582-4934.2009.00876.x", "ArticleIdList": ["10.1111/j.1582-4934.2009.00876.x", "PMC2832082", "19674190"]}, {"Citation": "Holmstrom KM, Finkel T (2014) Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol 15 (6):411\u2013421. doi:10.1038/nrm3801", "ArticleIdList": ["10.1038/nrm3801", "24854789"]}, {"Citation": "Ye ZW, Zhang J, Townsend DM, Tew KD (2015) Oxidative stress, redox regulation and diseases of cellular differentiation. Biochim Biophys Acta 1850 (8):1607\u20131621. doi:10.1016/j.bbagen.2014.11.010", "ArticleIdList": ["10.1016/j.bbagen.2014.11.010", "PMC4433447", "25445706"]}, {"Citation": "Halliwell B (1987) Free radicals and metal ions in health and disease. Proc Nutr Soc 46 (1):13\u201326", "ArticleIdList": ["3575319"]}, {"Citation": "Sassa H, Takaishi Y, Terada H (1990) The triterpene celastrol as a very potent inhibitor of lipid peroxidation in mitochondria. Biochem Biophys Res Commun 172 (2):890\u2013897", "ArticleIdList": ["2241977"]}, {"Citation": "Sassa H, Kogure K, Takaishi Y, Terada H (1994) Structural basis of potent antiperoxidation activity of the triterpene celastrol in mitochondria: effect of negative membrane surface charge on lipid peroxidation. Free Radic Biol Med 17 (3):201\u2013207", "ArticleIdList": ["7982625"]}, {"Citation": "Divya TDV, Soumyakrisnan S, Sureshkumar S, Sudandiran G. (2016) Celastrol enhances Nrf2 mediated antioxidant enzymes and exhibits anti-fibrotic effect through regulation of collagen production against bleomycin-induced pulmonary fibrosis. Chemico-Biological Interactions:Epub Ahead of Print", "ArticleIdList": ["26768587"]}, {"Citation": "Wang C, Shi C, Yang X, Yang M, Sun H, Wang C (2014) Celastrol suppresses obesity process via increasing antioxidant capacity and improving lipid metabolism. Eur J Pharmacol 744:52\u201358. doi:10.1016/j.ejphar.2014.09.043", "ArticleIdList": ["10.1016/j.ejphar.2014.09.043", "25300680"]}, {"Citation": "Chen G, Zhang X, Zhao M, Wang Y, Cheng X, Wang D, Xu Y, Du Z, Yu X (2011) Celastrol targets mitochondrial respiratory chain complex I to induce reactive oxygen species-dependent cytotoxicity in tumor cells. BMC Cancer 11:170. doi:10.1186/1471-2407-11-170", "ArticleIdList": ["10.1186/1471-2407-11-170", "PMC3112161", "21569548"]}, {"Citation": "Li HY, Zhang J, Sun LL, Li BH, Gao HL, Xie T, Zhang N, Ye ZM (2015) Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study. Cell Death Dis 6:e1604. doi:10.1038/cddis.2014.543", "ArticleIdList": ["10.1038/cddis.2014.543", "PMC4669742", "25611379"]}, {"Citation": "Gupta SC, Kim JH, Prasad S, Aggarwal BB (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29 (3):405\u2013434. doi:10.1007/s10555-010-9235-2", "ArticleIdList": ["10.1007/s10555-010-9235-2", "PMC2996866", "20737283"]}, {"Citation": "Pang X, Yi Z, Zhang J, Lu B, Sung B, Qu W, Aggarwal BB, Liu M (2010) Celastrol suppresses angiogenesis-mediated tumor growth through inhibition of AKT/mammalian target of rapamycin pathway. Cancer Res 70 (5):1951\u20131959", "ArticleIdList": ["PMC2854134", "20160026"]}, {"Citation": "Khan KA, Bicknell R (2015) Anti-angiogenic alternatives to VEGF blockade. Clinical & experimental metastasis", "ArticleIdList": ["PMC4761368", "26620208"]}, {"Citation": "Szekanecz Z, Besenyei T, Paragh G, Koch AE (2009) Angiogenesis in rheumatoid arthritis. Autoimmunity 42 (7):563\u2013573", "ArticleIdList": ["PMC2917919", "19863375"]}, {"Citation": "Koch AE (2000) The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 59 Suppl 1:i65\u201371", "ArticleIdList": ["PMC1766630", "11053092"]}, {"Citation": "Al-Husein B, Abdalla M, Trepte M, Deremer DL, Somanath PR (2012) Antiangiogenic therapy for cancer: an update. Pharmacotherapy 32 (12):1095\u20131111. doi:10.1002/phar.1147", "ArticleIdList": ["10.1002/phar.1147", "PMC3555403", "23208836"]}, {"Citation": "Gan K, Xu L, Feng X, Zhang Q, Wang F, Zhang M, Tan W (2015) Celastrol attenuates bone erosion in collagen-Induced arthritis mice and inhibits osteoclast differentiation and function in RANKL-induced RAW264.7. Int Immunopharmacol 24 (2):239\u2013246. doi:10.1016/j.intimp.2014.12.012", "ArticleIdList": ["10.1016/j.intimp.2014.12.012", "25529994"]}, {"Citation": "Dai Y, Desano J, Tang W, Meng X, Meng Y, Burstein E, Lawrence TS, Xu L (2010) Natural proteasome inhibitor celastrol suppresses androgen-independent prostate cancer progression by modulating apoptotic proteins and NF-kappaB. PLoS One 5 (12):e14153. doi:10.1371/journal.pone.0014153", "ArticleIdList": ["10.1371/journal.pone.0014153", "PMC3000808", "21170316"]}, {"Citation": "Ji N, Li J, Wei Z, Kong F, Jin H, Chen X, Li Y, Deng Y (2015) Effect of celastrol on growth inhibition of prostate cancer cells through the regulation of hERG channel in vitro. Biomed Res Int 2015:308475. doi:10.1155/2015/308475", "ArticleIdList": ["10.1155/2015/308475", "PMC4383143", "25866772"]}, {"Citation": "Zhou YX, Huang YL (2009) Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study. Chin Med J (Engl) 122 (14):1666\u20131673", "ArticleIdList": ["19719969"]}, {"Citation": "Huang L, Zhang Z, Zhang S, Ren J, Zhang R, Zeng H, Li Q, Wu G (2011) Inhibitory action of Celastrol on hypoxia-mediated angiogenesis and metastasis via the HIF-1alpha pathway. Int J Mol Med 27 (3):407\u2013415", "ArticleIdList": ["21249310"]}, {"Citation": "Huang S, Tang Y, Cai X, Peng X, Liu X, Zhang L, Xiang Y, Wang D, Wang X, Pan T (2012) Celastrol inhibits vasculogenesis by suppressing the VEGF-induced functional activity of bone marrow-derived endothelial progenitor cells. Biochem Biophys Res Commun 423 (3):467\u2013472", "ArticleIdList": ["22683631"]}, {"Citation": "Ni H, Zhao W, Kong X, Li H, Ouyang J (2013) Celastrol inhibits lipopolysaccharide-induced angiogenesis by suppressing TLR4-triggered nuclear factor-kappa B activation. Acta Haematol 131 (2):102\u2013111", "ArticleIdList": ["24157922"]}, {"Citation": "Huang Y, Zhou Y, Fan Y, Zhou D (2008) Celastrol inhibits the growth of human glioma xenografts in nude mice through suppressing VEGFR expression. Cancer Lett 264 (1):101\u2013106. doi:10.1016/j.canlet.2008.01.043", "ArticleIdList": ["10.1016/j.canlet.2008.01.043", "18343027"]}, {"Citation": "Zhang DH, Marconi A, Xu LM, Yang CX, Sun GW, Feng XL, Ling CQ, Qin WZ, Uzan G, d\u2019Alessio P (2006) Tripterine inhibits the expression of adhesion molecules in activated endothelial cells. J Leukoc Biol 80 (2):309\u2013319. doi:10.1189/jlb.1005611", "ArticleIdList": ["10.1189/jlb.1005611", "16769766"]}, {"Citation": "Wu F, Han M, Wilson JX (2009) Tripterine prevents endothelial barrier dysfunction by inhibiting endogenous peroxynitrite formation. Br J Pharmacol 157 (6):1014\u20131023", "ArticleIdList": ["PMC2737660", "19508391"]}, {"Citation": "Lindquist S, Craig EA (1988) The heat-shock proteins. Annu Rev Genet 22:631\u2013677", "ArticleIdList": ["2853609"]}, {"Citation": "Rajaiah R, Moudgil KD (2009) Heat-shock proteins can promote as well as regulate autoimmunity. Autoimmun Rev 8 (5):388\u2013393", "ArticleIdList": ["PMC2668694", "19121415"]}, {"Citation": "Adachi H, Katsuno M, Waza M, Minamiyama M, Tanaka F, Sobue G (2009) Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications. Int J Hyperthermia 25 (8):647\u2013654", "ArticleIdList": ["20021225"]}, {"Citation": "Arawaka S, Machiya Y, Kato T (2010) Heat shock proteins as suppressors of accumulation of toxic prefibrillar intermediates and misfolded proteins in neurodegenerative diseases. Curr Pharm Biotechnol 11 (2):158\u2013166", "ArticleIdList": ["20170473"]}, {"Citation": "Muchowski PJ, Wacker JL (2005) Modulation of neurodegeneration by molecular chaperones. Nat Rev Neurosci 6 (1):11\u201322", "ArticleIdList": ["15611723"]}, {"Citation": "Westerheide SD, Bosman JD, Mbadugha BN, Kawahara TL, Matsumoto G, Kim S, Gu W, Devlin JP, Silverman RB, Morimoto RI (2004) Celastrols as inducers of the heat shock response and cytoprotection. J Biol Chem 279 (53):56053\u201356060", "ArticleIdList": ["15509580"]}, {"Citation": "Francis SP, Kramarenko II, Brandon CS, Lee FS, Baker TG, Cunningham LL (2011) Celastrol inhibits aminoglycoside-induced ototoxicity via heat shock protein 32. Cell Death Dis 2:e195.", "ArticleIdList": ["PMC3181421", "21866174"]}, {"Citation": "Hughes D, Guttenplan JB, Marcus CB, Subbaramaiah K, Dannenberg AJ (2008) Heat shock protein 90 inhibitors suppress aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and DNA adduct formation. Cancer Prev Res (Phila) 1 (6):485\u2013493", "ArticleIdList": ["PMC2680610", "19138996"]}, {"Citation": "Zhang D, Xu L, Cao F, Wei T, Yang C, Uzan G, Peng B (2010) Celastrol regulates multiple nuclear transcription factors belonging to HSP90\u2019s clients in a dose- and cell type-dependent way. Cell Stress Chaperones 15 (6):939\u2013946", "ArticleIdList": ["PMC3024068", "20480272"]}, {"Citation": "Petronelli A, Pannitteri G, Testa U (2009) Triterpenoids as new promising anticancer drugs. Anticancer Drugs 20 (10):880\u2013892. doi:10.1097/CAD.0b013e328330fd90", "ArticleIdList": ["10.1097/CAD.0b013e328330fd90", "19745720"]}, {"Citation": "Yadav VR, Sung B, Prasad S, Kannappan R, Cho SG, Liu M, Chaturvedi MM, Aggarwal BB (2010) Celastrol suppresses invasion of colon and pancreatic cancer cells through the downregulation of expression of CXCR4 chemokine receptor. Journal of molecular medicine (Berlin, Germany) 88 (12):1243\u20131253", "ArticleIdList": ["PMC3142743", "20798912"]}, {"Citation": "Zheng L, Fu Y, Zhuang L, Gai R, Ma J, Lou J, Zhu H, He Q, Yang B (2014) Simultaneous NF-kappaB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo. Int J Cancer 135 (7):1721\u20131732. doi:10.1002/ijc.28810", "ArticleIdList": ["10.1002/ijc.28810", "24615207"]}, {"Citation": "Dai Y, DeSano JT, Meng Y, Ji Q, Ljungman M, Lawrence TS, Xu L (2009) Celastrol potentiates radiotherapy by impairment of DNA damage processing in human prostate cancer. Int J Radiat Oncol Biol Phys 74 (4):1217\u20131225. doi:10.1016/j.ijrobp.2009.03.057", "ArticleIdList": ["10.1016/j.ijrobp.2009.03.057", "PMC2745184", "19545787"]}, {"Citation": "Li-Weber M (2013) Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett 332 (2):304\u2013312. doi:10.1016/j.canlet.2010.07.015", "ArticleIdList": ["10.1016/j.canlet.2010.07.015", "20685036"]}, {"Citation": "Chiang KC, Tsui KH, Chung LC, Yeh CN, Chen WT, Chang PL, Juang HH (2014) Celastrol blocks interleukin-6 gene expression via downregulation of NF-kappaB in prostate carcinoma cells. PLoS One 9 (3):e93151. doi:10.1371/journal.pone.0093151", "ArticleIdList": ["10.1371/journal.pone.0093151", "PMC3963984", "24664372"]}, {"Citation": "Lu L, Shi W, Deshmukh RR, Long J, Cheng X, Ji W, Zeng G, Chen X, Zhang Y, Dou QP (2014) Tumor necrosis factor-alpha sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis. PLoS One 9 (11):e113783. doi:10.1371/journal.pone.0113783", "ArticleIdList": ["10.1371/journal.pone.0113783", "PMC4242672", "25419573"]}, {"Citation": "Mi C, Shi H, Ma J, Han LZ, Lee JJ, Jin X (2014) Celastrol induces the apoptosis of breast cancer cells and inhibits their invasion via downregulation of MMP-9. Oncol Rep 32 (6):2527\u20132532. doi:10.3892/or.2014.3535", "ArticleIdList": ["10.3892/or.2014.3535", "25310109"]}, {"Citation": "Yang HS, Kim JY, Lee JH, Lee BW, Park KH, Shim KH, Lee MK, Seo KI (2011) Celastrol isolated from Tripterygium regelii induces apoptosis through both caspase-dependent and -independent pathways in human breast cancer cells. Food Chem Toxicol 49 (2):527\u2013532. doi:10.1016/j.fct.2010.11.044", "ArticleIdList": ["10.1016/j.fct.2010.11.044", "21134410"]}, {"Citation": "Peng B, Xu L, Cao F, Wei T, Yang C, Uzan G, Zhang D (2010) HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way. Mol Cancer 9:79. doi:10.1186/1476-4598-9-79", "ArticleIdList": ["10.1186/1476-4598-9-79", "PMC2873437", "20398364"]}, {"Citation": "Sung B, Park B, Yadav VR, Aggarwal BB (2010) Celastrol, a triterpene, enhances TRAIL-induced apoptosis through the down-regulation of cell survival proteins and up-regulation of death receptors. J Biol Chem 285 (15):11498\u201311507", "ArticleIdList": ["PMC2857028", "20154087"]}, {"Citation": "Li GQ, Liu D, Zhang Y, Qian YY, Zhu YD, Guo SY, Sunagawa M, Hisamitsu T, Liu YQ (2013) Anti-invasive effects of celastrol in hypoxia-induced fibroblast-like synoviocyte through suppressing of HIF-1alpha/CXCR4 signaling pathway. Int Immunopharmacol 17 (4):1028\u20131036. doi:10.1016/j.intimp.2013.10.006", "ArticleIdList": ["10.1016/j.intimp.2013.10.006", "24144813"]}, {"Citation": "Xu J, Wu CL, Huang J (2015) [Effect of celastrol in inhibiting metastasis of lung cancer cells by influencing Akt signaling pathway and expressing integrins]. Zhongguo Zhong Yao Za Zhi 40 (6):1129\u20131133", "ArticleIdList": ["26226758"]}, {"Citation": "Xu J, Wu CL (2015) [Anti-metastasis of celastrol on esophageal cancer cells and its mechanism]. Sheng Li Xue Bao 67 (3):341\u2013347", "ArticleIdList": ["26109308"]}, {"Citation": "Zanphorlin LM, Alves FR, Ramos CH (2014) The effect of celastrol, a triterpene with antitumorigenic activity, on conformational and functional aspects of the human 90kDa heat shock protein Hsp90alpha, a chaperone implicated in the stabilization of the tumor phenotype. Biochim Biophys Acta 1840 (10):3145\u20133152. doi:10.1016/j.bbagen.2014.06.008", "ArticleIdList": ["10.1016/j.bbagen.2014.06.008", "24954307"]}, {"Citation": "Wang WB, Feng LX, Yue QX, Wu WY, Guan SH, Jiang BH, Yang M, Liu X, Guo DA (2012) Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90. J Cell Physiol 227 (5):2196\u20132206", "ArticleIdList": ["21866552"]}, {"Citation": "Yang H, Landis-Piwowar KR, Chen D, Milacic V, Dou QP (2008) Natural compounds with proteasome inhibitory activity for cancer prevention and treatment. Curr Protein Pept Sci 9 (3):227\u2013239", "ArticleIdList": ["PMC3303152", "18537678"]}, {"Citation": "Dou QP, Zonder JA (2014) Overview of proteasome inhibitor-based anti-cancer therapies: perspective on bortezomib and second generation proteasome inhibitors versus future generation inhibitors of ubiquitin-proteasome system. Current cancer drug targets 14 (6):517\u2013536", "ArticleIdList": ["PMC4279864", "25092212"]}, {"Citation": "Hoesel B, Schmid JA (2013) The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer 12:86.", "ArticleIdList": ["PMC3750319", "23915189"]}, {"Citation": "Idris AI, Libouban H, Nyangoga H, Landao-Bassonga E, Chappard D, Ralston SH (2009) Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo. Mol Cancer Ther 8 (8):2339\u20132347. doi:10.1158/1535-7163.MCT-09-0133", "ArticleIdList": ["10.1158/1535-7163.MCT-09-0133", "19671767"]}, {"Citation": "Wang KW, Mao JS, Tai YP, Pan YJ (2006) Novel skeleton terpenes from Celastrus hypoleucus with anti-tumor activities. Bioorg Med Chem Lett 16 (8):2274\u20132277. doi:10.1016/j.bmcl.2006.01.021", "ArticleIdList": ["10.1016/j.bmcl.2006.01.021", "16455245"]}, {"Citation": "Tao X, Cush JJ, Garret M, Lipsky PE (2001) A phase I study of ethyl acetate extract of the chinese antirheumatic herb Tripterygium wilfordii hook F in rheumatoid arthritis. J Rheumatol 28 (10):2160\u20132167", "ArticleIdList": ["11669150"]}, {"Citation": "Zhang W, Shi Q, Zhao LD, Li Y, Tang FL, Zhang FC, Zhang X (2010) The safety and effectiveness of a chloroform/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis. J Clin Rheumatol 16 (8):375\u2013378. doi:10.1097/RHU.0b013e3181fe8ad1", "ArticleIdList": ["10.1097/RHU.0b013e3181fe8ad1", "21085018"]}, {"Citation": "Ji W, Li J, Lin Y, Song YN, Zhang M, Ke Y, Ren Y, Deng X, Zhang J, Huang F, Yu D (2010) Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii. Clin Rheumatol 29 (9):1067\u20131072. doi:10.1007/s10067-010-1497-0", "ArticleIdList": ["10.1007/s10067-010-1497-0", "PMC2908750", "20563618"]}, {"Citation": "Gao ZG, Zang AC, Bai RX (1986) Radix Tripterygium Wilfordii Hook F in rheumatoid arthritis, ankylosing spondylitis and juvenile rheumatoid arthritis. Chin Med J (Engl) 99 (4):317\u2013320", "ArticleIdList": ["3098512"]}, {"Citation": "Patavino T, Brady DM (2001) Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern Med Rev 6 (5):460\u2013471", "ArticleIdList": ["11703166"]}, {"Citation": "Tao X, Younger J, Fan FZ, Wang B, Lipsky PE (2002) Benefit of an extract of Tripterygium Wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study. Arthritis and rheumatism 46 (7):1735\u20131743", "ArticleIdList": ["12124856"]}, {"Citation": "Goldbach-Mansky R, Wilson M, Fleischmann R, Olsen N, Silverfield J, Kempf P, Kivitz A, Sherrer Y, Pucino F, Csako G, Costello R, Pham TH, Snyder C, van der Heijde D, Tao X, Wesley R, Lipsky PE (2009) Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Annals of internal medicine 151 (4):229\u2013240, W249\u2013251", "ArticleIdList": ["PMC2938780", "19687490"]}, {"Citation": "Lv QW, Zhang W, Shi Q, Zheng WJ, Li X, Chen H, Wu QJ, Jiang WL, Li HB, Gong L, Wei W, Liu H, Liu AJ, Jin HT, Wang JX, Liu XM, Li ZB, Liu B, Shen M, Wang Q, Wu XN, Liang D, Yin YF, Fei YY, Su JM, Zhao LD, Jiang Y, Li J, Tang FL, Zhang FC, Lipsky PE, Zhang X (2014) Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Ann Rheum Dis. doi:10.1136/annrheumdis-2013-204807", "ArticleIdList": ["10.1136/annrheumdis-2013-204807", "24733191"]}, {"Citation": "Moudgil KD, Berman BM (2014) Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis. Expert review of clinical immunology 10 (7):819\u2013822", "ArticleIdList": ["PMC8060809", "24820012"]}, {"Citation": "Li H, Zhang YY, Tan HW, Jia YF, Li D (2008) Therapeutic effect of tripterine on adjuvant arthritis in rats. J Ethnopharmacol 118 (3):479\u2013484. doi:10.1016/j.jep.2008.05.028", "ArticleIdList": ["10.1016/j.jep.2008.05.028", "18577440"]}, {"Citation": "Li H, Jia YF, Pan Y, Pan DJ, Li D, Zhang LX (1997) Effect of tripterine on collagen-induced arthritis in rats. Zhongguo Yao Li Xue Bao 18 (3):270\u2013273", "ArticleIdList": ["10072949"]}, {"Citation": "Xu Z, Wu G, Wei X, Chen X, Wang Y, Chen L (2013) Celastrol induced DNA damage, cell cycle arrest, and apoptosis in human rheumatoid fibroblast-like synovial cells. Am J Chin Med 41 (3):615\u2013628. doi:10.1142/S0192415X13500432", "ArticleIdList": ["10.1142/S0192415X13500432", "23711145"]}, {"Citation": "Li GQ, Zhang Y, Liu D, Qian YY, Zhang H, Guo SY, Sunagawa M, Hisamitsu T, Liu YQ (2012) Celastrol inhibits interleukin-17A-stimulated rheumatoid fibroblast-like synoviocyte migration and invasion through suppression of NF-kappaB-mediated matrix metalloproteinase-9 expression. Int Immunopharmacol 14 (4):422\u2013431. doi:10.1016/j.intimp.2012.08.016", "ArticleIdList": ["10.1016/j.intimp.2012.08.016", "22954486"]}, {"Citation": "Zhou LL, Lin ZX, Fung KP, Cheng CH, Che CT, Zhao M, Wu SH, Zuo Z (2011) Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-kappaB activity. Eur J Pharmacol 670 (2\u20133):399\u2013408. doi:10.1016/j.ejphar.2011.09.014", "ArticleIdList": ["10.1016/j.ejphar.2011.09.014", "21951963"]}, {"Citation": "Zhu F, Li C, Jin XP, Weng SX, Fan LL, Zheng Z, Li WL, Wang F, Wang WF, Hu XF, Lv CL, Liu P (2014) Celastrol may have an anti-atherosclerosis effect in a rabbit experimental carotid atherosclerosis model. International journal of clinical and experimental medicine 7 (7):1684\u20131691", "ArticleIdList": ["PMC4132129", "25126165"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["27671821", "NIHMS1689895", "PMC8056454", "10.1007/978-3-319-41334-1_12"]}}], "PubmedBookArticle": []}